DK0596935T3 - Antivirale farmaceutiske midler til vaginal administration - Google Patents

Antivirale farmaceutiske midler til vaginal administration

Info

Publication number
DK0596935T3
DK0596935T3 DK92915980.4T DK92915980T DK0596935T3 DK 0596935 T3 DK0596935 T3 DK 0596935T3 DK 92915980 T DK92915980 T DK 92915980T DK 0596935 T3 DK0596935 T3 DK 0596935T3
Authority
DK
Denmark
Prior art keywords
vaginal administration
antiviral pharmaceuticals
tablets
antiviral
pharmaceuticals
Prior art date
Application number
DK92915980.4T
Other languages
Danish (da)
English (en)
Inventor
Ubaldo Conte
Lauretta Maggi
Original Assignee
L C Pharchem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L C Pharchem Ltd filed Critical L C Pharchem Ltd
Application granted granted Critical
Publication of DK0596935T3 publication Critical patent/DK0596935T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92915980.4T 1991-07-26 1992-07-20 Antivirale farmaceutiske midler til vaginal administration DK0596935T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI912071A IT1251114B (it) 1991-07-26 1991-07-26 Forme farmaceutiche antivirali per applicazione vaginale
CN92111077A CN1082894A (zh) 1991-07-26 1992-08-24 阴道给药的抗病毒药物组合物

Publications (1)

Publication Number Publication Date
DK0596935T3 true DK0596935T3 (da) 1996-01-22

Family

ID=36790864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92915980.4T DK0596935T3 (da) 1991-07-26 1992-07-20 Antivirale farmaceutiske midler til vaginal administration

Country Status (10)

Country Link
EP (1) EP0596935B1 (fr)
JP (1) JPH06509348A (fr)
CN (1) CN1082894A (fr)
AT (1) ATE129149T1 (fr)
AU (1) AU2345492A (fr)
CA (1) CA2114216A1 (fr)
DE (1) DE69205579T2 (fr)
DK (1) DK0596935T3 (fr)
IT (1) IT1251114B (fr)
WO (1) WO1993002662A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
DE4404011A1 (de) * 1994-02-09 1995-08-10 Jenapharm Gmbh Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
US6818672B1 (en) 1999-10-05 2004-11-16 Columbia Laboratories, Inc. Treating endometriosis or infertility, or improving fertility
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
JP2001240558A (ja) * 2000-02-29 2001-09-04 Nippon Suisan Kaisha Ltd 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
EP1318790A4 (fr) * 2000-09-19 2006-02-01 Cima Labs Inc Compositions pharmaceutiques pour administration par voie rectale et vaginale
EP1667619A4 (fr) * 2003-09-19 2007-10-10 Drugtech Corp Systeme pharmaceutique d'administration
AU2004311879B2 (en) 2003-12-31 2010-08-05 Cima Labs Inc. Effervescent oral opiate dosage form
WO2005065319A2 (fr) 2003-12-31 2005-07-21 Cima Labs Inc. Forme galenique de fentanyl generalement lineaire effervescente et orale et ses procedes d'administration
EP2662086A1 (fr) * 2012-05-08 2013-11-13 Progressare Medinvest B.V. Composition pour le traitement ou la prévention des infections des voies urinaires et forme galénique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
JPS58152809A (ja) * 1982-03-05 1983-09-10 Eisai Co Ltd 安定な発泡性「膣」坐剤
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
IT1187750B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release

Also Published As

Publication number Publication date
AU2345492A (en) 1993-03-02
EP0596935B1 (fr) 1995-10-18
ITMI912071A1 (it) 1993-01-27
DE69205579D1 (de) 1995-11-23
ITMI912071A0 (it) 1991-07-26
WO1993002662A1 (fr) 1993-02-18
CN1082894A (zh) 1994-03-02
EP0596935A1 (fr) 1994-05-18
JPH06509348A (ja) 1994-10-20
IT1251114B (it) 1995-05-04
DE69205579T2 (de) 1996-04-04
CA2114216A1 (fr) 1993-02-18
ATE129149T1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
DK0528734T3 (da) Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
NO942835L (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
DK0596935T3 (da) Antivirale farmaceutiske midler til vaginal administration
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DK254787D0 (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
IT8920486A0 (it) Composizioni farmaceutiche.
MX9201969A (es) Formulacion de tableta optimizada.
ITMI910404A0 (it) Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
ATE173930T1 (de) Pharmazeutische zusammensetzungen zur topischen anwendung die ein chelatierungsmittel, ein tocopherol und einen antimikrobiellen wirkstoff enthalten
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
HRP20000781B1 (en) Effervescent preparations
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
NO913661L (no) Anordning og fremgangsmaate for dosering av vaskemiddelkompositter.
DK0511991T3 (da) Farmaceutisk formulering
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
NL194918B (nl) SDK-peptide, en therapeutische preparaten die deze bevatten.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
IT8721958A0 (it) Derivato di taurina, sua preparazione e composizioni farmaceutiche relative
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
IT8721457A0 (it) Composizioni farmaceutiche antivirali.
DE69003003D1 (de) Pharmazeutische Zusammensetzung.